CHAPTER 4
Elena
◆
The PICU held its breath under the night lighting. Two rooms lit half, the rest set to the dim amber the unit used after midnight. Somewhere at bay six a pulse-ox alarmed once and reset. Elena listened for a second beep that did not come and turned back to her chart-review station.
No one had contacted her about the remote access attempt logged the previous night. The silence bothered her more than a warning would have.
The Foundation portal looked harsher under night lighting: blue-gray field, white type, her live credentials in the upper corner.
Elena had carried the path in her notebook since the previous shift—pediatric research, ORP, Q3.
Tonight, with two stable patients and the charge nurse three bays away, she opened the file from the hospital workstation.
The census was stable. Cole had gone home at eleven.
Charge nurse Bev sat at her own station three bays down, feet tucked under her on the swivel chair, scrolling triage.
Elena had two patients, both post-op cardiac, both mending: heart rate 118 and 124, sats 96 percent and 98 percent, urine output within range.
The kind of shift where a nurse either read a novel or found something else to do with her attention.
She clicked into Foundation_Q3_ORP_2025.pdf. Four-point-two megabytes. The little wheel spun for a beat and the document opened full-screen.
It resembled an internal accounting sheet.
Header in Foundation gray. Off-Register Procurement, Q3, 2025.
Hundreds of medication entries filled five columns: drug name, NDC, vial count, billed unit cost, subtotal.
Dobutamine. Milrinone. Nitroprusside. Epinephrine.
Immunoglobulin. Elena knew every name and most of the labels by sight.
Her eye tracked the per-vial column first, because that was where a nurse looked. Dobutamine at eighty-four thousand a vial. Milrinone at sixty-one thousand five hundred. Epinephrine at forty-two thousand nine hundred.
She stopped scrolling.
She read the three lines again, one number at a time.
Actual acquisition prices varied by contract and manufacturer, but none approached the figures on the screen. A routine vial had been inflated into the price of a house. These were not misplaced decimals. They were invented numbers attached to real medications.
She turned her watch toward her. Two thirty-one. Fixing the time in her mind gave the moment an edge she could hold.
The subtotals reached eight figures in a single week. No twelve-bed cardiac PICU could consume that volume of ordinary vasoactive medication, and no legitimate pharmacy budget could hide it.
Okay, she thought, clinical assent to nothing, and reached for her phone.
She opened the FDA’s National Drug Code database. She typed the first NDC from the milrinone line into the search field. The record came back: real manufacturer, real product, real dosage form. She typed the second, from epinephrine. Real. The NDCs matched labels she had held in her hand yesterday.
Real medications wearing invented prices.
She sat with that for one full minute, hands flat on the desk, breath at her nose instead of her mouth.
A monitor at bay four chirped a low-battery warning; she rose, walked the three steps to bay four, swapped the pack from the crash cart, and came back.
Bev did not look up. The corridor beyond the doors was empty.
The unit smelled of alcohol wipes and the faint sweet-formula smell that never left a pediatric floor, and under both, from the linen cart parked in the anteroom, the dry starched note of freshly laundered isolette drapes.
She sat down.
She opened her email. New message. Subject: Foundation Q3—medication-line anomaly, please review.
To: [email protected].
Body, three sentences. Ms. Whitmore, I opened the attached PDF from the Foundation portal tonight.
The billed unit costs are thousands of times higher than plausible pharmacy pricing.
Two NDCs match valid products in the FDA database, which suggests the drug identifiers are real and the financial entries are not a simple data-entry error.
Elena opened a second browser window and checked ordinary contract prices through the hospital pharmacy reference, not the public search alone.
The difference grew worse. Even allowing for shortages, handling, and manufacturer variation, the ledger’s amounts were not inflated costs.
They were invented wealth attached to familiar medicine.
She built a small comparison table in her notebook.
Dobutamine: listed eighty-four thousand. Contract range: single digits.
Milrinone: listed sixty-one thousand five hundred. Contract range: low tens.
Epinephrine: listed forty-two thousand nine hundred. Contract range: less than the meal she had not eaten.
The totals climbed past mistake and into design.
Before she finished, bed two’s mother woke and found Elena at the workstation. “Everything okay?” she asked, eyes going immediately to the monitor through the glass.
“With your daughter, yes.” Elena turned the screen away from the corridor on instinct. “Her pressure is stable. She has another blood gas at four.”
The mother nodded and returned to the bedside.
The exchange clarified Elena’s obligation. Whatever lived in the file used children’s medicine as camouflage. Reporting it was not curiosity. It was part of protecting the institution those families trusted.
She addressed the email to Renée Whitmore because the finance orientation packet named Renée as the Foundation’s internal-control officer. She copied the secure compliance mailbox, not Cole, and attached only the file she had found through her authorized access.
Before sending, Elena wrote one more sentence.
Please preserve the access logs and confirm whether I should stop using the portal pending review.
She reread the message for accusation and removed none. It described what she knew and asked for action. That was enough.
She attached Foundation_Q3_ORP_2025.pdf, checked the filename, the address, the compliance copy, and the attachment icon. At two forty-seven, she sent it.
Her pulse ran fast but regular. Appropriate to circumstance. She left the message in her sent folder and the evidence where it belonged.
The email left her outbox with an ordinary chime. No alarm followed. No security warning. Bed five’s pump continued its soft mechanical rhythm.
Nothing changed at once.
For the next hour she worked deliberately.
The seven-month-old in bay two needed a diaper change and a temperature check: ninety-nine even.
The child in bay five needed pressure care, so Elena and Amara turned him together and checked every line before settling him.
She reconciled medications for morning report, verified both pumps, restocked linen, and stayed out of the Foundation portal.
The dead hours passed. The corridor did not stir. Her watch face, upside down against her sternum, ticked past four.
At twelve minutes past four Bev picked up the floor phone after two rings. Elena heard her side of the call—yes, she’s on. Yes. Alright. Bev set the receiver down and looked over. Bev’s face did not change. That was the part that told Elena to stand up.
Two men came through the unit doors, both in dark suits.
The taller one had the kind of ex-military bearing that walked wide of doorframes.
The other was younger, brown-haired, fair, unremarkable.
Neither wore a hospital badge. Neither said hospital-security.
The taller one stopped a proper professional distance from the workstation and said, at low volume, without a smile,
“Ms. Rossi.”
He said it like he already knew, which he did. He nodded once at Bev—a nod that was polite and finished—and gestured, palm up, toward the double doors.
Elena logged out, capped her pen, and made her movements calm enough for the room. “I’ll be back, or someone will call you.” Bev wrote the time and both men’s descriptions in the shift log before saying, “Okay.”
Elena went with them.
She went because they used her name, kept a professional distance, and did not threaten anyone in a pediatric intensive care unit. Refusing inside the ward would turn a private problem into a scene around sleeping children. She chose movement, memorized both faces, and kept her hands free.
They took the service elevator. The younger man pressed ten. No one spoke. The car smelled like fresh vinyl and someone’s cold coffee.
Floor ten North was administration. Carpet instead of tile. The lighting warmer than the units. Renée Whitmore’s suite sat at the end of the corridor and the door was open, which was how Elena knew what was happening even before she saw her.
Renée stood at her office threshold in a charcoal suit, at four in the morning, silver-blonde bob unruffled.
She was fifty and looked it, which on her read as authority.
She stayed at the threshold. She offered no words.
She met Elena’s eyes as the three of them passed and held them for as long as one drawn breath, and she inclined her chin once, a small business-like nod, neither warm nor cold, and let them by.
The email had been read. Renée had been up when it arrived. Renée had picked up a phone.
Elena read the exchange, put it away, and kept walking.
A private elevator carried them from ten North to the fourth floor. They crossed the glass skybridge into South Tower while the East River lay black below, dotted with barge lights. Her reflection kept pace beside her: tired face, soft-blue scrubs, hair in a low knot.
At the South Tower landing, they took a carpeted stair up one flight. The taller man went first, the younger behind her. At the top, he opened an unmarked door into a corridor Elena had never seen.
The corridor opened into a small reception. Empty desk. One lamp. A door beyond, tall, matte-black.
The younger man knocked once and opened it.
Nikolai’s office was spare and severe: a Kandinsky print, a wall of glass over the East River, an old dark desk, one lit lamp. He sat behind it in a white shirt with the top button open and the sleeves rolled once. A tumbler of whiskey rested untouched near his elbow.
He stayed seated.
He lifted his eyes when she entered—pale gray, colder in the low light—and waited for the door to close.
“Sit down, please, Ms. Rossi.”
He gestured at the leather chair across the desk. She sat. She put her hands flat on her thighs, palms down, so that if they shook nobody would see. Her watch pressed a small cold circle against her sternum.
He turned the laptop so the screen faced her. The document on it was Foundation_Q3_ORP_2025.pdf, opened to the dobutamine line. Her flag, essentially. He had not enlarged anything.
“Tell me what you’re looking at.”
Five words. Unhurried. He waited.
She had thought, in the elevator, about how she wanted to answer this. Clinically. In the register she used at the bedside when she paged a resident. She kept her voice at that register now.
“The medication costs are wrong by several thousand percent.”
He held still. His gaze stayed on her. He waited on the rest.
“Dobutamine cannot cost eighty-four thousand dollars a vial. Milrinone and epinephrine are inflated the same way. I checked two NDCs; the products are real. The prices are not.”
She stopped talking there, because she had said the arithmetic and it did not need embellishment. Her breath was even. Her hands were flat.
He opened an access log beside the PDF. Elena recognized the format even though the header was too small to read.
“How long have you had access?”
“Since Tuesday night. The ethics module unlocked it.”
He acknowledged that with a slight nod.
He read four names off the second screen.
“Cole. Whitmore. Halvorsen. Rossi. Your account, your credentials.”
“Yes. I sent the email at two forty-seven.”
He absorbed that. His hand rested on the desk beside the laptop. He left the whiskey untouched.
The office was so quiet she could hear the laptop fan. A tug moved beyond the glass. Leather, cedar, and a trace of whiskey scented the room. The drink had been poured before she arrived and forgotten; that small detail made him seem less composed than his face suggested.
Elena reached across the desk and tapped the filename at the top of the reader window. “This was stored inside the pediatric-research tree.”
Something sharpened in his expression. He turned the screen back toward himself.
The location mattered. They both understood that.
He looked at the screen a moment longer, then closed the laptop lid. The click of it was small. He kept his hand on the case.
“You did the honest thing. That gives me options.”
She let the sentence settle, then asked the question that mattered.
“Am I in trouble, Dr. Romanov?”
His eyes held hers without a smile.
“You are in danger. Trouble implies you caused it.”
Fear tightened beneath her ribs, but her voice remained steady. “How much danger?”
He took a breath, one beat, choosing.
“Then you have three choices, Ms. Rossi.”